Clinical Trial Update: Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma [Phase 3]

View source ↗

Summary

This Phase 3 trial assesses whether adding temozolomide to radiation therapy improves outcomes for patients with low-grade glioma and is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Brain and Central Nervous System Tumors, Neurotoxicity | Phase 3 | Status: ACTIVE_NOT_RECRUITING